ResMed downgraded at JPMorgan and RBC despite earnings beat
ResMed (RMD) traded lower Friday despite posting better than expected financials for Q4 fiscal 2022 after JPMorgan and RBC Capital Markets moved to downgrade the dual-listed…
ResMed downgraded at JPMorgan and RBC despite earnings beat
ResMed (RMD) traded lower Friday despite posting better than expected financials for Q4 fiscal 2022 after JPMorgan and RBC Capital Markets moved to downgrade the dual-listed…